Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. David Meek bought Bluebird Bio last year ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Amylyx ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

AI giant Anthropic has already become a dominant player in technology and a household name for everyday users of artificial ...

AstraZeneca agreed to pay $34 million to settle claims that the company paid kickbacks to improperly influence prescriptions ...

Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever outbreak in central Africa.

Vijay Kumar, acting director of the office that reviews cell and gene therapies at the Food and Drug Administration, is ...

Demand for alcohol is declining. The industry is fighting harder and more creatively than ever against limits — and winning.